Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
株式のランク #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
株価
$36.75
最終同期: 2026-08-27
時価総額
$1.63B
変化(1日)
-0.78%
変化(1年)
-
US
取引 Avalyn Pharma Inc. Common Stock (AVLN)

カテゴリー

Avalyn Pharma Inc. Common Stock(AVLN)の株価履歴
終値の最高値: $36.94 (2026-08-01)

終値の最安値: $29.49 (2026-04-01)
Avalyn Pharma Inc. Common Stock の株価履歴(2026 ~ 2026)
年間株価パフォーマンス
パフォーマンス
提供された日付のデータは十分ではありません。
類似企業または競合の株価
企業 株価 変化率 1年%
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$761.87 7.26%
CH